PHASE-III RANDOMIZED STUDY OF ALL-TRANS-RETINOIC ACID (ATRA) VS DAUNORUBICIN (D) END CYTOSINE-ARABINOSIDE (A) AS INDUCTION THERAPY AND ATRAVS OBSERVATION AS MAINTENANCE THERAPY FOR PATIENTS WITH PREVIOUSLY UNTREATED ACUTE PROMYELOCYTIC LEUKEMIA (APL)

TALLMAN MS ANDERSEN J SCHIFFER CA APPELBAUM FR FEUSNER JE WOODS WG OGDEN A WEINSTEIN H SHEPHERD L ROWE JM WIERNIK PH

Ms. Tallman et al., PHASE-III RANDOMIZED STUDY OF ALL-TRANS-RETINOIC ACID (ATRA) VS DAUNORUBICIN (D) END CYTOSINE-ARABINOSIDE (A) AS INDUCTION THERAPY AND ATRAVS OBSERVATION AS MAINTENANCE THERAPY FOR PATIENTS WITH PREVIOUSLY UNTREATED ACUTE PROMYELOCYTIC LEUKEMIA (APL), Blood, 86(10), 1995, pp. 488-488

NO

Hematology

Blood → ACNP

00064971

86

10

1995

1

488 - 488

ISI

0006-4971(1995)86:10<488:PRSOAA>2.0.ZU;2-X